Vasco Gama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vasco Gama has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Francisco Sampaio
Department of Cardiology, Unidade Local de Saúde de Gaia e Espinho, Vila Nova de Gaia, Portugal
3 shared publications - Nuno Bettencourt
Universidade do Porto, Portugal
3 shared publications - Pedro Braga
Cardiology, Centro Hospitalar de Vila Nova de Gaia / Espinho, Vila Nova de Gaia, PRT
3 shared publications - Ricardo Fontes-Carvalho
RISE-Health, Departamento de Cirurgia e Fisiologia, Faculdade de Medicina, Universidade do Porto, Porto, Portugal; Serviço de Cardiologia, Unidade Local de Saúde Gaia/Espinho, Vila Nova de Gaia, Portugal
3 shared publications Adelaide Dias
Cardiology Department, Vila Nova de Gaia Hospital Centre, Vila Nova de Gaia, Portugal
2 shared publications- Adelino Ferreira Leite-Moreira
University of Porto
2 shared publications
Latest Publications
- Open Access
Numerical Study of the Unsteady Flow in Simplified and Realistic Iliac Bifurcation Models
Cardiovascular diseases are a major cause of death and disability worldwide and they are commonly associated with the occurrence of atherosclerotic plaque deposition in the vessel walls, a process denoted as atherosclerosis. This is a chronic and progressive inflammatory disease of large-/medium-sized blood vessels that affects blood flow profiles, with the abdominal aorta and its branches being one of the locations prone to the development of this pathology, due to their curvatures and bifurcations. In this regard, the effect of flow patterns was studied and compared for both a simplified three-dimensional model of aorta bifurcation on the iliac arteries and a realistic model of iliac bifurcation, which was constructed from a computational tomography medical image. The flow patterns were analyzed in terms of velocity and wall shear stress distribution, but a special focus was given to the size and location of the recirculation zone. The simulations were performed using the Computational Fluid Dynamics software, FLUENT, taking into account the cardiac cycle profile at the infrarenal aorta. The shear stress and the velocity distribution observed for both models indicated that higher shear stress occurred along the flow divider wall (inner wall) and low shear stress occurred along the outer walls. In addition, the results demonstrated that the wall shear stress profiles were deeply affected by the transient profile of the cardiac cycle, with the deceleration phase being the most critical phase to the occurrence of backflow.
Open AccessNumerical Study of the Unsteady Flow in Simplified and Realistic Iliac Bifurcation Models
Cardiovascular diseases are a major cause of death and disability worldwide and they are commonly associated with the occurrence of atherosclerotic plaque deposition in the vessel walls, a process denoted as atherosclerosis. This is a chronic and progressive inflammatory disease of large-/medium-sized blood vessels that affects blood flow profiles, with the abdominal aorta and its branches being one of the locations prone to the development of this pathology, due to their curvatures and bifurcations. In this regard, the effect of flow patterns was studied and compared for both a simplified three-dimensional model of aorta bifurcation on the iliac arteries and a realistic model of iliac bifurcation, which was constructed from a computational tomography medical image. The flow patterns were analyzed in terms of velocity and wall shear stress distribution, but a special focus was given to the size and location of the recirculation zone. The simulations were performed using the Computational Fluid Dynamics software, FLUENT, taking into account the cardiac cycle profile at the infrarenal aorta. The shear stress and the velocity distribution observed for both models indicated that higher shear stress occurred along the flow divider wall (inner wall) and low shear stress occurred along the outer walls. In addition, the results demonstrated that the wall shear stress profiles were deeply affected by the transient profile of the cardiac cycle, with the deceleration phase being the most critical phase to the occurrence of backflow.
- 8 April 2021
- Published by Springer Nature in Endocrine
- Vol. 72 (3) , 699-710
Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial
Purpose Metabolic syndrome (MetS) affects one out of 3 adults in the western world and is associated with preclinical diastolic dysfunction that impairs functional capacity and quality of life (QoL). This randomized trial was designed to evaluate if the addition of metformin to the standard treatment of non-diabetic patients with MetS improves diastolic dysfunction. Methods Prospective, randomized, open-label, blinded-endpoint trial. Fifty-four non-diabetic adults with MetS and diastolic dysfunction were randomized to lifestyle counseling or lifestyle counseling plus metformin (target dose 1000 mg bid). The primary endpoint was the change in mean e’ velocity (assessed at baseline, 6, 12 and 24 months). Secondary endpoints were improvements in insulin resistance, functional capacity and QoL. Linear mixed effects modeling was used for longitudinal data analysis using modified intention-to-treat (mITT) and per-protocol (PP) approaches. Results Forty-nine patients were included in the mITT analysis (mean age = 51.8 ± 6.4; 55% males). Metformin treatment was associated with a significant decrease in HOMA-IR. There was a significantly different mean change in e’ velocity during the study period between trial arms, both in the mITT (at 24 months, change of +0.67 ± 1.90 cm/s in metformin arm vs. −0.33 ± 1.50 cm/s in control arm) and PP populations (+0.80 ± 1.99 cm/s in metformin arm vs. −0.37 ± 1.52 cm/s in control arm), using a random intercept linear mixed model. There were no significant differences in peak oxygen uptake and SF-36 scores between trial arms. Conclusions Treatment with metformin of non-diabetic MetS patients with diastolic dysfunction, on top of lifestyle counseling, is associated with improved diastolic function.
- 8 April 2021
- Published by Springer Nature in Endocrine
- Vol. 72 (3) , 699-710
Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial
Purpose Metabolic syndrome (MetS) affects one out of 3 adults in the western world and is associated with preclinical diastolic dysfunction that impairs functional capacity and quality of life (QoL). This randomized trial was designed to evaluate if the addition of metformin to the standard treatment of non-diabetic patients with MetS improves diastolic dysfunction. Methods Prospective, randomized, open-label, blinded-endpoint trial. Fifty-four non-diabetic adults with MetS and diastolic dysfunction were randomized to lifestyle counseling or lifestyle counseling plus metformin (target dose 1000 mg bid). The primary endpoint was the change in mean e’ velocity (assessed at baseline, 6, 12 and 24 months). Secondary endpoints were improvements in insulin resistance, functional capacity and QoL. Linear mixed effects modeling was used for longitudinal data analysis using modified intention-to-treat (mITT) and per-protocol (PP) approaches. Results Forty-nine patients were included in the mITT analysis (mean age = 51.8 ± 6.4; 55% males). Metformin treatment was associated with a significant decrease in HOMA-IR. There was a significantly different mean change in e’ velocity during the study period between trial arms, both in the mITT (at 24 months, change of +0.67 ± 1.90 cm/s in metformin arm vs. −0.33 ± 1.50 cm/s in control arm) and PP populations (+0.80 ± 1.99 cm/s in metformin arm vs. −0.37 ± 1.52 cm/s in control arm), using a random intercept linear mixed model. There were no significant differences in peak oxygen uptake and SF-36 scores between trial arms. Conclusions Treatment with metformin of non-diabetic MetS patients with diastolic dysfunction, on top of lifestyle counseling, is associated with improved diastolic function.
- Open Access
- 24 April 2018
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 18 (1) , 69
Thrombus aspiration in patients with ST-elevation myocardial infarction: results of a national registry of interventional cardiology
We aimed to evaluate the impact of thrombus aspiration (TA) during primary percutaneous coronary intervention (P-PCI) in ‘real-world’ settings. We performed a retrospective study, using data from the National Registry of Interventional Cardiology (RNCI 2006–2012, Portugal) with ST-elevation myocardial infarction (STEMI) patients treated with P-PCI. The primary outcome, in-hospital mortality, was analysed through adjusted odds ratio (aOR) and 95% confidence intervals (95%CI). We assessed data for 9458 STEMI patients that undergone P-PCI (35% treated with TA). The risk of in-hospital mortality with TA (aOR 0.93, 95%CI:0.54–1.60) was not significantly decreased. After matching patients through the propensity score, TA reduced significantly the risk of in-hospital mortality (OR 0.58, 95%CI:0.35–0.98; 3500 patients). The whole cohort data does not support the routine use of TA in P-PCI, but the results of the propensity-score matched cohort suggests that the use of selective TA may improve the short-term risks of STEMI.
- 24 April 2018
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 18 (1) , 69
Open AccessThrombus aspiration in patients with ST-elevation myocardial infarction: results of a national registry of interventional cardiology
We aimed to evaluate the impact of thrombus aspiration (TA) during primary percutaneous coronary intervention (P-PCI) in ‘real-world’ settings. We performed a retrospective study, using data from the National Registry of Interventional Cardiology (RNCI 2006–2012, Portugal) with ST-elevation myocardial infarction (STEMI) patients treated with P-PCI. The primary outcome, in-hospital mortality, was analysed through adjusted odds ratio (aOR) and 95% confidence intervals (95%CI). We assessed data for 9458 STEMI patients that undergone P-PCI (35% treated with TA). The risk of in-hospital mortality with TA (aOR 0.93, 95%CI:0.54–1.60) was not significantly decreased. After matching patients through the propensity score, TA reduced significantly the risk of in-hospital mortality (OR 0.58, 95%CI:0.35–0.98; 3500 patients). The whole cohort data does not support the routine use of TA in P-PCI, but the results of the propensity-score matched cohort suggests that the use of selective TA may improve the short-term risks of STEMI.
- Open Access
- 1 November 2017
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 36 (11) , 833-842
Extracorporeal membrane oxygenation in circulatory and respiratory failure – A single-center experience
- 1 November 2017
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 36 (11) , 833-842
Open AccessExtracorporeal membrane oxygenation in circulatory and respiratory failure – A single-center experience
- Open Access
- 19 October 2017
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 9 (1) , 1-10
Association of body mass index and visceral fat with aortic valve calcification and mortality after transcatheter aortic valve replacement: the obesity paradox in severe aortic stenosis
Previous studies showed that metabolic syndrome is associated with aortic valve calcification (AVC) and poor outcomes in aortic stenosis (AS). However, if these associations change and how body fat impacts the prognosis of patients in late stage of the disease have been not yet explored. To determine the association of body mass index (BMI) and visceral fat with AVC and mortality after transcatheter aortic valve replacement (TAVR). This was a prospective cohort of 170 severe AS patients referred to TAVR. We quantified AVC mass score and fat depots including epicardial adipose tissue, intrathoracic fat, and abdominal visceral (VAF) and subcutaneous fats by computed tomography. Fat depots were indexed to body surface area. All-cause and cardiovascular-related deaths after TAVR were recorded over a median follow-up of 1.2 years. Higher AVC mass was independently associated with low BMI and low VAF. All-cause mortality risk increased with the decrease of BMI and increment of VAF. A stratified analysis by obesity showed that in non-obese, VAF was inversely associated with mortality, whereas in obese, high VAF was associated with higher mortality (p value for interaction < 0.05). At long-term, hazard ratio [HR] with non-obese/low VAF was 2.3 (95% confidence interval [CI] 1.1–4.9; p = 0.021) and HR with obese/high VAF was 2.5 (95% CI 1.1–5.8; p = 0.031) compared with obese/low VAF patients. In AS patients submitted to TAVR, BMI and VAF were inversely associated with AVC. Pre-intervention assessment of VAF by computed tomography may provide a better discrimination of mortality than BMI alone.
- 19 October 2017
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 9 (1) , 1-10
Open AccessAssociation of body mass index and visceral fat with aortic valve calcification and mortality after transcatheter aortic valve replacement: the obesity paradox in severe aortic stenosis
Previous studies showed that metabolic syndrome is associated with aortic valve calcification (AVC) and poor outcomes in aortic stenosis (AS). However, if these associations change and how body fat impacts the prognosis of patients in late stage of the disease have been not yet explored. To determine the association of body mass index (BMI) and visceral fat with AVC and mortality after transcatheter aortic valve replacement (TAVR). This was a prospective cohort of 170 severe AS patients referred to TAVR. We quantified AVC mass score and fat depots including epicardial adipose tissue, intrathoracic fat, and abdominal visceral (VAF) and subcutaneous fats by computed tomography. Fat depots were indexed to body surface area. All-cause and cardiovascular-related deaths after TAVR were recorded over a median follow-up of 1.2 years. Higher AVC mass was independently associated with low BMI and low VAF. All-cause mortality risk increased with the decrease of BMI and increment of VAF. A stratified analysis by obesity showed that in non-obese, VAF was inversely associated with mortality, whereas in obese, high VAF was associated with higher mortality (p value for interaction < 0.05). At long-term, hazard ratio [HR] with non-obese/low VAF was 2.3 (95% confidence interval [CI] 1.1–4.9; p = 0.021) and HR with obese/high VAF was 2.5 (95% CI 1.1–5.8; p = 0.031) compared with obese/low VAF patients. In AS patients submitted to TAVR, BMI and VAF were inversely associated with AVC. Pre-intervention assessment of VAF by computed tomography may provide a better discrimination of mortality than BMI alone.
- 1 December 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 201, 260-261
First-in-human transcatheter aortic valve-in-valve replacement with the SAPIEN 3 heart valve
- 1 December 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 201, 260-261
First-in-human transcatheter aortic valve-in-valve replacement with the SAPIEN 3 heart valve
- Open Access
- 1 June 2014
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 33 (6) , 389.e1-389.e5
Interrupted aortic arch: A misdiagnosed cause of hypertension
- 1 June 2014
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 33 (6) , 389.e1-389.e5
Open AccessInterrupted aortic arch: A misdiagnosed cause of hypertension
- 1 March 2014
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 25 (3) , 241-246
Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis
- 1 March 2014
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 25 (3) , 241-246
Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis
- 1 October 2011
- Vol. 18 (4) , 199-207
[Percutaneous intervention in left main coronary disease: medium and long term clinical outcomes in a high risk population].
Coronary artery bypass graft (CABG) remains the standard therapy for left main coronary artery (LMCA) disease.However, in recent years, percutaneous coronary intervention (PCI) has shown good results and is being used in an increasing number of patients. We aimed to assess mid and long term clinical outcomes of patients undergoing LMCA PCI in a hospital with cardiac surgery. Retrospective analysis of consecutive patients undergoing LMCA PCI between January 2005 and June 2011.F our groups (G) of indications for PCI were defined: G1 - patients refused for surgery (29.2%), G2 - emergent PCI (14.6%),G3 - PCI of protected LMCA (37.5%) and G4 - LMCA PCI as preferred revascularization strategy due to favorable coronary anatomy (18.8%). Ninety-six patients were treated, mostly male (69.8%), mean age of 69.4±10.5 years. Most patients (69%) had acute coronary syndrome and 14% were in cardiogenic shock. Critical stenosis of distal LMCA was seen in 58% and drug-eluting stents were used in 60%. Mean logistic EuroScore was 13.9±11.9%. Patients from groups 1, 2 and 3 had more multivessel disease (96, 79 and 89%, respectively) than those from G4 (isolated LMCA disease in 58%). Follow-up was performed in 100% of patients (median of 21 months; IQR 10.0 - 43.5), with a total mortality rate of 28.1% (14.6% of cardiovascular (CV) causes). Seven patients (7.3%) had in-hospital death. MACCE rate (CV death, nonfatal myocardial infarction, stroke and LMCA reintervention) was 26% and one-year mortality was 15.4%. Five patients (5.6%) required percutaneous reintervention; CABG was performed only in 1 patient.In subgroup analysis it was found that total mortality in G1 and G2 (46.4% and 64.3%) was significantly higher than that of G3 and G4 (11.1% and 5.6% respectively), p <0.001. The same trend was observed for CV mortality: G1 (25.0%) and G2 (35.7%) vs G3 (5.6%) and G4 (0%), p = 0.005. LMCA PCI proved to be a safe technique with low mortality in patients with protected LMCA and those with favorable coronary anatomy for percutaneous revascularization. Patients undergoing emergent PCI or refused for surgery had a large number of events, according to their very high baseline risk profile.
- 1 October 2011
- Vol. 18 (4) , 199-207
[Percutaneous intervention in left main coronary disease: medium and long term clinical outcomes in a high risk population].
Coronary artery bypass graft (CABG) remains the standard therapy for left main coronary artery (LMCA) disease.However, in recent years, percutaneous coronary intervention (PCI) has shown good results and is being used in an increasing number of patients. We aimed to assess mid and long term clinical outcomes of patients undergoing LMCA PCI in a hospital with cardiac surgery. Retrospective analysis of consecutive patients undergoing LMCA PCI between January 2005 and June 2011.F our groups (G) of indications for PCI were defined: G1 - patients refused for surgery (29.2%), G2 - emergent PCI (14.6%),G3 - PCI of protected LMCA (37.5%) and G4 - LMCA PCI as preferred revascularization strategy due to favorable coronary anatomy (18.8%). Ninety-six patients were treated, mostly male (69.8%), mean age of 69.4±10.5 years. Most patients (69%) had acute coronary syndrome and 14% were in cardiogenic shock. Critical stenosis of distal LMCA was seen in 58% and drug-eluting stents were used in 60%. Mean logistic EuroScore was 13.9±11.9%. Patients from groups 1, 2 and 3 had more multivessel disease (96, 79 and 89%, respectively) than those from G4 (isolated LMCA disease in 58%). Follow-up was performed in 100% of patients (median of 21 months; IQR 10.0 - 43.5), with a total mortality rate of 28.1% (14.6% of cardiovascular (CV) causes). Seven patients (7.3%) had in-hospital death. MACCE rate (CV death, nonfatal myocardial infarction, stroke and LMCA reintervention) was 26% and one-year mortality was 15.4%. Five patients (5.6%) required percutaneous reintervention; CABG was performed only in 1 patient.In subgroup analysis it was found that total mortality in G1 and G2 (46.4% and 64.3%) was significantly higher than that of G3 and G4 (11.1% and 5.6% respectively), p <0.001. The same trend was observed for CV mortality: G1 (25.0%) and G2 (35.7%) vs G3 (5.6%) and G4 (0%), p = 0.005. LMCA PCI proved to be a safe technique with low mortality in patients with protected LMCA and those with favorable coronary anatomy for percutaneous revascularization. Patients undergoing emergent PCI or refused for surgery had a large number of events, according to their very high baseline risk profile.
- 1 May 2010
- Vol. 29 (5) , 827-36
Cor triatriatum sinistrum--description and review of four cases.
Cor triatriatum sinistrum is a rare congenital cardiac anomaly in which the left atrium is divided into two compartments by a fibromuscular membrane. In most cases, the two cavities communicate through one or more openings. It is generally associated with other cardiac anomalies. The clinical manifestations depend mainly on the size of the fibromuscular membrane orifice(s) and the pressure gradient between the two cavities. The authors present four cases of cor triatriatum sinistrum diagnosed in different clinical contexts and age-groups. In all cases the diagnosis was based on echocardiographic findings (transthoracic and transesophageal) and was supplemented by other imaging modalities.
- 1 May 2010
- Vol. 29 (5) , 827-36
Cor triatriatum sinistrum--description and review of four cases.
Cor triatriatum sinistrum is a rare congenital cardiac anomaly in which the left atrium is divided into two compartments by a fibromuscular membrane. In most cases, the two cavities communicate through one or more openings. It is generally associated with other cardiac anomalies. The clinical manifestations depend mainly on the size of the fibromuscular membrane orifice(s) and the pressure gradient between the two cavities. The authors present four cases of cor triatriatum sinistrum diagnosed in different clinical contexts and age-groups. In all cases the diagnosis was based on echocardiographic findings (transthoracic and transesophageal) and was supplemented by other imaging modalities.